Riskpilot← Back to searchSign inGet full accessVERDALSØRA LEGESENTER AS
ASActiveOrg 918264507Jernbanegata 9L, 7650 VerdalGeneral medical practice activities · NACE 8621Est. 20174 employees
Revenue 2025
NOK 3,9M
0% vs 2024
EBITDA margin
-5.8%
-1125% vs 2024
Equity ratio
-37.0%
Financial strength
Net profit 2025
NOK -265K
-956% vs 2024
| Revenue | NOK 3,9M | +0% |
| EBITDA | NOK -224K | -1125% |
| Net profit | NOK -265K | -956% |
| Total assets | NOK 507K | -27% |
| Equity | NOK -187K | -343% |
| Employees | 4 | — |
Legal name
VERDALSØRA LEGESENTER AS
Org number
918264507
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
27. mars 2017
Share capital
NOK 40 000
Employees
4 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap. Styrets medlemmer hver for seg.
Company purpose
Drive legesenter, helsetjenester, informasjon, salg samt deltagelse i selskaper av samme eller annen art gjennom aksjetegning eller på annen måte.
Address
Jernbanegata 9L, 7650 Verdal
Phone
+4774070700
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 3 723 | 3 341 | 3 894 | 3 902 | 3 890 |
| Staff expenses | −1 806 | −1 816 | −2 027 | −2 067 | −2 237 |
| EBITDA | 245 | −118 | 110 | 22 | −224 |
| Depreciation & amort. | −112 | −108 | −60 | −38 | −34 |
| EBIT | 133 | −226 | 50 | −16 | −258 |
| Net financials | −10 | −10 | −11 | −9 | −7 |
| Profit before tax | 123 | −236 | 39 | −25 | −265 |
| Tax | 27 | 9 | −0 | −0 | −0 |
| Net profit | 96 | −246 | 39 | −25 | −265 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 949 | 823 | 1 383 | 690 | 507 |
| Equity | 309 | 63 | 102 | 77 | −187 |
| Long-term debt | 198 | 162 | 124 | 84 | 40 |
| Short-term debt | 442 | 598 | 1 156 | 529 | 654 |
| Total debt | 640 | 760 | 1 281 | 613 | 694 |
EBITDA margin
-5.8%
This company
15.8%
Market median
-137% vs market
20212025
Equity ratio
-37.0%
This company
38.2%
Market median
-197% vs market
20212025
Return on equity
-26465800.0%
This company
18.4%
Market median
-143835970% vs market
20212025
Net profit margin
-6.8%
This company
8.1%
Market median
-184% vs market
20212025
Asset turnover
7.67×
This company
1.12×
Market median
+585% vs market
20212025
Debt / equity
3.71×
This company
0.62×
Market median
-498% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
KS Chief Executive Officer | Chief Executive Officer | 2017 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Former (1) | ||
| Board of Directors | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of VERDALSØRA LEGESENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kjetil Sørdal Klungre | Chief Executive Officer | 0 companies |
| Dag Asting Solberg | Chairman | 0 companies |
| Janne Limandvik Myhr | Board of Directors | 0 companies |
| Hege Graneng Nesbø | Board of Directors | 0 companies |
| Line Stensland | Board of Directors | 0 companies |
| Line Stensland-Nesset | Board of Directors | 0 companies |